Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)
Young & Partners reviews what happened in 2017, the future outlook and the implications for management
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)
Young & Partners looks at the big picture trends and the nuances underneath
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)
Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different
The Highs, Lows and the Unexpected – Young & Partners (ICIS Chemical Business Sept 8 – 14, 2017 issue)
Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)
Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017
Young & Partners examines the biopharma stock market and M&A trends and their implications
Fire and Ice – Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)
While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be
Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)
First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)
Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
Peter Young – Chemical Heritage Foundation Bolte Award (2017)
Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
In M&A, Now You See It, Now You Don’t – Young & Partners ICIS Chemical Business Feb 24, 2017 issue)
Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.